SLC5A5 and thyroid cancer, nonmedullary, 2: [14] assessed the methylation of the NIS promoter in 100 bp upstream and downstream, extending to the first intron, of CpG-rich dinucleotides (named P, L, C regions) and its expression in PTC and FTC tumor tissues.